- Home
- CGEM vs GES Comparison
CGEM vs GES Comparison
Compare CGEM & GES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEM
- GES
- Stock Information
- Founded
- CGEM 2016
- GES 1981
- Country
- CGEM United States
- GES Switzerland
- Employees
- CGEM N/A
- GES N/A
- Industry
- CGEM Biotechnology: Pharmaceutical Preparations
- GES Apparel
- Sector
- CGEM Health Care
- GES Consumer Discretionary
- Exchange
- CGEM Nasdaq
- GES Nasdaq
- Market Cap
- CGEM 530.0M
- GES 547.7M
- IPO Year
- CGEM 2021
- GES 1996
- Fundamental
- Price
- CGEM $7.82
- GES $12.98
- Analyst Decision
- CGEM Strong Buy
- GES Buy
- Analyst Count
- CGEM 5
- GES 4
- Target Price
- CGEM $30.00
- GES $17.75
- AVG Volume (30 Days)
- CGEM 367.2K
- GES 910.9K
- Earning Date
- CGEM 08-07-2025
- GES 08-27-2025
- Dividend Yield
- CGEM N/A
- GES 9.24%
- EPS Growth
- CGEM N/A
- GES N/A
- EPS
- CGEM N/A
- GES 0.10
- Revenue
- CGEM N/A
- GES $3,051,131,000.00
- Revenue This Year
- CGEM N/A
- GES $7.34
- Revenue Next Year
- CGEM N/A
- GES $3.20
- P/E Ratio
- CGEM N/A
- GES $134.25
- Revenue Growth
- CGEM N/A
- GES 9.02
- 52 Week Low
- CGEM $6.85
- GES $8.48
- 52 Week High
- CGEM $21.01
- GES $24.64
- Technical
- Relative Strength Index (RSI)
- CGEM 44.54
- GES 65.56
- Support Level
- CGEM $7.26
- GES $11.80
- Resistance Level
- CGEM $8.05
- GES $12.16
- Average True Range (ATR)
- CGEM 0.44
- GES 0.46
- MACD
- CGEM -0.07
- GES 0.10
- Stochastic Oscillator
- CGEM 32.55
- GES 96.07
About CGEM Cullinan Oncology Inc.
Cullinan Therapeutics Inc is a biopharmaceutical company. It has a diversified portfolio of clinical-stage assets that inhibit key drivers of disease or harness the immune system to eliminate diseased cells in both oncology and autoimmune diseases. Its understanding of oncology, immunology, and translational medicine, creates differentiated ideas, identifies the appropriate targets, and selects the optimal modality to develop transformative therapeutics across a variety of cancer and autoimmune indications. It has one reporting and one operating segment, which is the business of developing immunology and oncology therapies.
About GES Guess? Inc.
Guess? Inc designs, markets distributes, and licenses contemporary apparel and accessories that reflect European fashion sensibilities and American Lifestyle under brands including Guess, Marciano, and G by Guess. The company has five reportable segments: Americas Retail, Americas Wholesale, Europe, Asia, and licensing. Geographically, the company derives maximum revenue from the United States.